Mark Lomaga

1.9k total citations
8 papers, 260 citations indexed

About

Mark Lomaga is a scholar working on Dermatology, Immunology and Surgery. According to data from OpenAlex, Mark Lomaga has authored 8 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 5 papers in Immunology and 2 papers in Surgery. Recurrent topics in Mark Lomaga's work include Psoriasis: Treatment and Pathogenesis (4 papers), Dermatology and Skin Diseases (4 papers) and Hormonal and reproductive studies (1 paper). Mark Lomaga is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), Dermatology and Skin Diseases (4 papers) and Hormonal and reproductive studies (1 paper). Mark Lomaga collaborates with scholars based in Canada, United States and Spain. Mark Lomaga's co-authors include Yves Dutronc, Andreas Pinter, J.‐P. Lacour, Giuseppe Micali, Stefan Wilhelm, Lars E. French, C. Paul, Kristian Reich, Carlos Ferrándiz and Susanne Hartz and has published in prestigious journals such as Journal of Neuroscience, British Journal of Dermatology and Acta Dermato Venereologica.

In The Last Decade

Mark Lomaga

7 papers receiving 259 citations

Peers

Mark Lomaga
Comparison fields: 5 of 49
  • Immunology 208
  • Dermatology 128
  • Molecular Biology 44
  • Rheumatology 39
  • Cancer Research 36
Replace Martina Merli with:
Martina Merli Italy
Rachael Jarrett United Kingdom
Saki Fukaya Japan
Samantha Beswick United Kingdom
Chih-Hsun Yang Taiwan
Raluca Popescu Romania
Adriane Peveling‐Oberhag Germany
Zhongbin Lai United States
Ayako Matsuki Japan
Naïma Oumouhou France
Martina Merli Italy View profile →
Citations per field, relative to Mark Lomaga
Mark Lomaga · 1×
Citations per year, relative to Mark Lomaga
Mark Lomaga · 1×

Countries citing papers authored by Mark Lomaga

Since Specialization
Citations

This map shows the geographic impact of Mark Lomaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lomaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lomaga more than expected).

Fields of papers citing papers by Mark Lomaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lomaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lomaga. The network helps show where Mark Lomaga may publish in the future.

Co-authorship network of co-authors of Mark Lomaga

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lomaga. A scholar is included among the top collaborators of Mark Lomaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lomaga. Mark Lomaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Work Indexed citations
1 1
2 0
3 9
4 13
5 159
6 9
7
Priapism as a possible acute side effect of radical radiotherapy for prostate cancer.
1
8 68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026